£790.00

It has never been this cheap. We have no record of a lower price.

£790 today · cheaper than every other day in the last 3 months

World Outlook: Alpha-1 Antitrypsin Deficiency Treatments

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 18 days · 18 data points (no recent data)

Historical
Generating forecast…
£790.00 £750.50 £766.30 £782.10 £797.90 £813.70 £829.50 11 August 2026 15 August 2026 19 August 2026 23 August 2026 28 August 2026
View at Amazon ↗

Price data last checked 73 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 18 days • 1 price levels

Days at Price
18 days 0 5 9 14 18 £790 Days at Price

Price Analysis

Most common price: £790 (18 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 18 days

Description
This comprehensive study provides a detailed world outlook for alpha-1 antitrypsin deficiency treatments from 2025 to 2030. Covering more than 190 countries, the report delivers essential data for understanding global market dynamics and potential industry earnings (P.I.E.). By utilizing econometric models that project fundamental economic dynamics within and across individual nations, this report offers precise latent demand estimates. Readers can access specific data for each reported year, including the percent share a country holds within its region and across the entire globe. These comparative benchmarks are designed to help professionals quickly gauge a country's market position relative to others, making it a vital resource for economic analysis in the pharmaceutical sector.

Key Features

Covers the world outlook for alpha-1 antitrypsin deficiency treatments across more than 190 countries.

Provides annual estimates for latent demand and potential industry earnings (P.I.E.) in millions of U.S. dollars.

Includes comparative benchmarks showing the percent share of each country relative to its region and the globe.

Utilizes econometric models to project fundamental economic dynamics within and across different countries.

Offers a detailed market analysis spanning the years 2025 through 2030.

Product Specifications
Format
paperback
ASIN
B0CZLZ5NM1
Category
Books > Subjects
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
09 May 2024